Aptevo Therapeutics (APVO) Income from Discontinued Operations (2016 - 2023)
Aptevo Therapeutics (APVO) reported Income from Discontinued Operations of $293,000 for Q4 2023, down 43.8% from $521,000 a year earlier.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Income from Discontinued Operations (2016 - 2023) Analysis & Trends
For FY2023, Aptevo Therapeutics posted Income from Discontinued Operations of $1.24 million, up 22.3% from FY2022.
- Income from Discontinued Operations has a four-year compound annual growth rate of -17.0% (FY2019 to FY2023).
- By year, Income from Discontinued Operations came in at $1.01 million in FY2022 (+6.5%), $951,000 in FY2021 (-92.8%), $13.17 million in FY2020 (+403.6%) and $2.62 million in FY2019.
- The Q4 2023 figure ranks as the lowest quarterly Income from Discontinued Operations since Q3 2022.
- Year over year, Income from Discontinued Operations gained in four of the last six quarters, with growth averaging 85.0%.
- The high point for year-over-year Income from Discontinued Operations in five years was Q1 2023 (growth of 431.5%); the low point was Q1 2021 (a decline of 96.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 8.00 Mn |
| 10 | Aptevo Therapeutics | 2.50 Mn | -64.50 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 293,000.00 |
| Mar 31, 2023 | 946,000.00 |
| Dec 31, 2022 | 521,000.00 |
| Sep 30, 2022 | 165,000.00 |
| Jun 30, 2022 | 149,000.00 |
| Mar 31, 2022 | 178,000.00 |
| Dec 31, 2021 | 325,000.00 |
| Sep 30, 2021 | 80,000.00 |
| Jun 30, 2021 | 132,000.00 |
| Mar 31, 2021 | 414,000.00 |
| Dec 31, 2020 | 118,000.00 |
| Sep 30, 2020 | 157,000.00 |
| Mar 31, 2020 | 12.90 Mn |
| Dec 31, 2019 | 1.22 Mn |
| Sep 30, 2019 | 4.16 Mn |
| Jun 30, 2019 | -2.49 Mn |
| Mar 31, 2019 | -277,000.00 |
| Sep 30, 2018 | 39,000.00 |
| Jun 30, 2018 | 11,000.00 |
| Mar 31, 2018 | 54,000.00 |
API Access
Aptevo Therapeutics Income from Discontinued Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-discontinued-operations", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();